谈及在代谢增强型CD19 CAR-T已铺开多项临床，为何仍投入资源进行体内CAR-T研究时，仝督读表示，这也是“对公司技术平台通用性的验证”。“如果我们的免疫代谢重编程技术能在体内CAR-T这一热门领域解决疗效不足和安全性等相关问题，更能证明技术平台的实力。”
Joe TidyCyber correspondent, BBC World Service
。旺商聊官方下载是该领域的重要参考
VFDs with full-size CRTs typical of other computer terminals, and conventional
My technique had changed at this point. Since he was trying multiple things, well, I had to as well.